Month: June 2021

Researchers at the Barcelona Institute for Global Health (ISGlobal) have carried out an epidemiological study that they claim addresses some weaknesses of previous, similar studies, and supports a proposed link between maternal use of paracetamol (acetaminophen) during pregnancy, and symptoms of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum conditions (ASC) in their children. The newly reported
0 Comments
Biopharma 4.0 provides facility designers and builders with the opportunity to show how physical premises can support advanced manufacturing technologies. Which begs the question: What will 4.0-enabled facilities of the future look like? Will we be able to tell from the outside where they lie on the continuum of Industry 1.0, 2.0, 3.0, 4.0? It’s
0 Comments
Azzur Cleanrooms on Demand™ (COD), an Azzur Group company, opened in May in San Diego, as part of the company’s program to offer serviced cleanroom facilities to biotech clusters across the U.S. “Our immediate plan is to cover hotbeds in the United States, such as Philadelphia, Raleigh, and the growing biotech community in Texas,” explains
0 Comments
Until now, the ability of T lymphocytes to distinguish between healthy and infected cells was deemed to be near perfect. New research findings published in eLife show this is not the case. T lymphocytes use TCRs (T cell receptors) to establish the difference between the body’s own cells, whose recognizable cell surface peptide-signposts or antigens
0 Comments
Through an investigation of patients with a rare form of amyotrophic lateral sclerosis (ALS), researchers have discovered a new and unique form of the disease. The new clinical study reveals two major findings: 1) a single genetic cause of early-onset ALS and 2) a novel, metabolism-associated, molecular pathway that may contribute to neurodegeneration in other
0 Comments
Danaher acquired Precision NanoSystems (PNI), which develops technologies and solutions for genetic medicines, including mRNA vaccines and therapeutics. The Vancouver, Canada-based company will join Danaher’s life sciences platform, complementing the portfolios of both Cytiva and Pall, according to Emmanuel Ligner, Danaher group executive. “PNI has advanced a number of exciting innovations and we’re thrilled to
0 Comments
Manhattan’s commercial landlords, stewards of a half-billion square feet of office floors, will be sweating out the usually restful season between Memorial Day and Labor Day, praying that the much-anticipated return-to-offices really happens.  Compounding their anxiety are out-of-date rules for workplaces that were drafted by the state in the pandemic’s terrible early phase — and
0 Comments